The drug, L-DOPA that is prescribed for Parkinson’s patients was found to delay the onset of age-related macular degeneration in adults.
Make Treatment of Parkinsons More Affordable, Doctors Plead
The Parkinson's disease occurs when certain nerve cells in the brain, called the substantia nigra, die or become impaired.
The Parkinson's disease occurs when certain nerve cells in the brain, called the substantia nigra, die or become impaired.
‘Age-related macular degeneration (AMD) is the leading cause of severe vision loss in people over age 60. It destroys the central portion of the retina known as the macula, impairing central vision.
’
L-DOPA is frequently prescribed for Parkinson's patients. They reported that patients receiving L-DOPA were significantly less likely to get AMD, and when they did, its onset was significantly delayed. Senior author Brian McKay of the University of Arizona said that rather than looking at what might cause AMD, they instead wondered why certain people were protected from AMD.
BrightFocus president Stacy Pagos Haller said that this exciting breakthrough showed the power of scientific discovery to give hope to millions of people across the nation and the world. The study is published in the American Journal of Medicine.
Cerebrospinal Fluid Biomarkers Examined in Early Parkinson Disease
In a group of untreated patients compared with healthy patients, cerebrospinal fluid (CSF) levels of tau proteins, ɑ-synuclein, and β-amyloid 1-42 (Αβ1-42) appear to be associated with early stage Parkinson disease.
In a group of untreated patients compared with healthy patients, cerebrospinal fluid (CSF) levels of tau proteins, ɑ-synuclein, and β-amyloid 1-42 (Αβ1-42) appear to be associated with early stage Parkinson disease.
Alzheimer Disease and Parkinson Disease Do Not Appear To Share Common Genetic Risk: Study
The genetic overlap between Parkinson disease (PD) and Alzheimer disease (AD) were examined by a study.
The genetic overlap between Parkinson disease (PD) and Alzheimer disease (AD) were examined by a study.
Exercising In Virtual Environment Could Help Parkinson Patients Cope With Walking Problems
Exercising in virtual environment could help Parkinson patients to cope with walking problems, Australian researchers believe.
Exercising in virtual environment could help Parkinson patients to cope with walking problems, Australian researchers believe.
